Facebook Linkedin Mail X Youtube
Facebook Linkedin Mail X Youtube
    Latest

    Latest News

    Miracor secures US$10M financing round to develop RAMSES clinical trials and strengthen product sales

    Mesoblast receives European clearance to begin trial of allogeneic stem cell treatment for heart attacks

    ESC guidelines recommend prasugrel for patients with NSTEMI and unstable angina

    Everolimus-eluting stent shows encouraging results in STEMI patients

    Prolonged antiplatelet therapy no better than six-month regimen

    Exposure of physicians to radiation prompts cellular changes that may protect the body from harm

    ESC sets consensus over TAVI

    Barostim neo is CE marked for the treatment of uncontrolled hypertension

    Panel publishes advisory on diagnosing and managing patients with chronic heart failure and anaemia

    RE-ALIGN trial to start evaluation of dabigatran etexilate in patients with mechanical heart valves

    “The lower the heart rate, the better the quality of life,” SHIFT study shows

    European Society of Cardiology launches upgraded risk measurement tool for heart attacks and strokes

    High baseline resting heart rate is associated with a higher prevalence and severity of angina and heart attacks, CLARIFY registry confirms

    New CT scan may speed up heart disease diagnosis with less radiation

    New NICE guideline will radically change how high blood pressure is diagnosed

    Coronary artery stenting viable palliative option for infants and toddlers

    TRIAS two-year follow-up data show no stent thrombosis with Genous stent

    No erosion associated with the Gore Helex Septal Occluder

    First patient treated in Japan with Abbott’s Absorb BVS

    Medtronic receives CE mark for 31mm CoreValve percutaneous aortic valve

    Edwards lifesciences launches physio tricuspid heart valve repair ring

    University of Münster bridges first patient to transplant with SynCardia’s Total Artificial Heart

    Estrogen could help protect women from cardiovascular disease, new research shows

    10 milllion patients diagnosed with ACIST contrast delivery system

    Siemens improves its angiography systems with navigation technology from St. Jude Medical

    First renal denervation treatment for resistant hypertension performed in Latin America

    FDA approves RX Herculink Elite renal stent system for treatment of renal artery disease

    Stem cell researchers uncover reason why the adult human heart cannot regenerate itself

    Pradaxa (dabigatran etexilate) gets approval for stroke prevention in AF patients in Europe

    Promising early results with new transapical TAVI device

    Bioengineered stent safe and effective in cases where prolonged dual antiplatelet therapy is not advisable

    FDA recommends approval of Edwards Sapien transcatheter valve

    Mitroflow aortic pericardial heart valve gets CE mark

    Resolute drug-eluting stent superior than Taxus drug-eluting stent, Japanese study shows

    FDA approves Brilinta (ticagrelor)

    Neutralisable anticoagulant found to be well tolerated in healthy subjects, study shows

    Cardinal Health launches molecular imaging collaboration center

    Genous stent is safe to use after early discontinuation of dual antiplatelet therapy

    St. Jude Medical’s diagnostic technology receives CE mark

    CryoLife makes equity investment in ValveXchange

    Lantheus Medical Imaging initiates phase III clinical trial of Flurpiridaz F 18 for the detection of coronary artery disease

    FDA clears EV1000 clinical monitoring platform

    Biotronik announces first patients treated in BIOFLOW-II clinical study

    InfraReDx initiates CANARY clinical trial of LipiScan IVUS coronary imaging guidance

    PCI shows promising results in patients with infarction and thrombosis of the unprotected left main coronary artery

    Non-invasive FFR superior to CT angiography for diagnosis of lesion-specific ischaemia

    SynCardia’s Total Artificial Heart presented at TechConnect World Summit

    Micell Technologies reduces clinical trial sample size for MiStent drug-eluting coronary stent based on early clinical data

    NICE recommends use of Brilique (ticagrelor) in patients who have had a heart attack or episode of unstable angina

    New NICE quality standards published on chronic heart failure

    ESC calls for greater awareness of potential for adverse events from bleeding as a result of percutaneous coronary intervention

    ESC calls for renaming of term cardiac hypertrophy

    SeptRx begins CE mark trial of intrapocket PFO occluder

    Positive results for unprotected left main coronary artery PCI with drug-eluting stents

    Pitavastatin demonstrates sustained increases in HDL-C and offers atheroprotective benefits

    Ticagrelor reduces cardiovascular events and deaths compared to clopidogrel

    Cappella Medical introduces new longer Sideguard coronary sidebranch stents

    Drug-eluting coronary stents using biodegradable polymer significantly improve overall clinical outcomes

    Cordis will stop developing drug-eluting coronary stents

    Rapiscan (regadenoson) is launched in the United Kingdom

    APOLLO trial shows sustained benefits at 18 months in cardiac cell therapy

    First implant of St Jude Medical’s Portico transcatheter heart valve

    CoreValve study shows rapid and sustained health-related quality-of-life improvements

    Favourable clinical study results reported with dual antiplatelet therapy after left atrial appendage closure with Watchman device

    Juventas Therapeutics completes phase I clinical trial for JVS-100

    FDA approves Trifecta valve

    LipiScan IVUS coronary imaging system receives CE mark

    FDA approves ION Platinum Chromium stent system

    PARTNER finds TAVI as good as surgery

    Absorb shows positive one-year safety and efficacy results

    Abbott launches MitraClip system in Australia

    EVEREST II study demonstrates MitraClip’s durable clinical benefits for patients with mitral regurgitation, two years after treatment

    Medrad Interventional introduces next generation Fetch2 aspiration catheter

    GE Healthcare IT and TomTec work together to enhance cardiology patient care

    CardioNexus introduces CardioHealth Station at ACC Sesions 2011

    Platelet inhibition of PA32540 shows superior results over a standard of care regimen

    New EAE position statement tries to tackle misuse of pocket-size echo devices

    Triple antiplatelet therapy reduces restenosis in long lesions after drug-eluting stent implantation

    A fifth of ACS treated patients develop major cardiac events within three years

    Coronary artery calcium scans may help patients lower heart disease risk

    NICE releases guidance to use hypothermia as a treatment option after cardiac arrest

    Omega Platinum Chromium Coronary Stent System is implanted for the first time in the UK

    University of Michigan Cardiovascular Center participates in the CoreValve clinical trial

    Stentys expands operations into four additional European countries

    Lantheus Medical Imaging receives FDA’s special protocol assessment for phase III clinical trial of flurpiridaz F-18

    OrbusNeich launches its Azule Cobalt Chromium stent

    Edwards Lifesciences acquires Embrella Cardiovascular

    Medtronic launches Contour 3D Annuloplasty Ring for the treatment of tricuspid valve disease

    Ziehm Imaging launches hybrid edition mobile C-arm

    Pfizer Health Solutions launches OwnHealth Choice

    Edwards receives CE mark approval for a larger version of its Sapien XT transcatheter aortic valve

    Boston Scientific completes acquisition of Atritech

    New dual drug-eluting stent effective in decreasing in-stent late loss

    One third of TAVI patients require permanent pacemaker within 30 days

    COSIRA trial begins patient enrolment to treat refractory angina

    Omega Platinum Chromium Stent System is approved in Europe

    Eagle Eye Platinum Digital IVUS catheter receives Japanese clearance

    Nile Therapeutics to collaborate with Medtronic on clinical development of cenderitide for heart failure and renal disease

    SCAI publishes statement on standards for quality assessment and improvement in interventional cardiology

    Next-generation Sapphire II coronary dilatation catheter is commercially available

    Medtronic’s Mosaic heart valve demonstrates long-term durability up to 12 years in international study

    e-HEALING registry shows positive clinical outcomes for OrbusNeich’s Genous Stent

    Micell Technologies enrolls first patient in DESSOLVE II clinical trial

    Boston Scientific launches Promus Element and Taxus Element Stent Systems in India

    Registry for CoreValve system confirms positive clinical outcomes

    Registry will investigate the Genous stent in patients with acute coronary syndrome and high-risk of post-procedural bleeding

    New absorbable stent era begins

    CE mark for Peripatch-BV bovine pericardial tissue

    SCAI publishes consensus document about radiation exposure to the pregnant interventional cardiologist and technical staff

    Vascular Solutions acquires Zerusa Ltd, manufacturer of the Guardian haemostasis valves

    FDA announces cardiovascular risks added to rosiglitazone (Avandia) labels

    New imaging modality receives CE mark

    FDA gives conditional approval for pivotal study to evaluate robotic-assisted placement of coronary guidewires and stent/balloon catheters

    Boston Scientific begins clinical trial enrolment in China for Promus Element everolimus-eluting stent

    Bio-engineered stent safe in high-risk patients with contraindications for dual antiplatelet therapy

    Xience Prime receives the CE mark for treatment of critical limb ischaemia in the lower limb

    Occurrence of stroke after coronary artery bypass graft surgery appears to be decreasing, study shows

    SCAI publishes radiation safety programme principles for cardiac catheterisation labs

    Volcano’s IVUS and VH IVUS technologies can assess the risk of individual blockages better than the use of the current standard of care angiographic imaging alone, PROSPECT study shows

    Boston Scientific completes enrollment in EVOLVE clinical trial to evaluate Synergy drug-eluting coronary stent

    Medtronic revises design of CoreValve US pivotal trial

    St. Jude Medical announces launch of the ViewMate Z intracardiac ultrasound system and ViewFlex Plus ICE catheter

    Minimal differences in the use of radial artery graft and saphenous vein graft for coronary artery bypass grafting

    AccessClosure announces launch of new Mynx Cadence vascular closure device

    World’s first drug-eluting bioresorbable stent receives the CE mark

    Boston Scientific completes acquisition of Sadra Medical

    First patient is enrolled in US pivotal study of the Tryton Side Branch Stent

    HeartWare files FDA pre-market approval application of HeartWare Ventricular Assist System

    Meril Life Sciences’ Biomime sirolimus-eluting stent receives the CE mark

    Miracor receives CE mark for the PICSO Impulse System

    Landmark Medtronic CoreValve US clinical trial begins

    Stem cell therapy demonstrates significant reperfusion in severe heart attack patients

    St Jude Medical launches new Trifecta valve in Canada

    Nano-measurement of troponin levels proves an accurate predictor of deterioration in heart failure

    Stentys begins large-scale study with its self-apposing stent for treatment of heart attacks

    Medtronic CoreValve system gains CE mark for new subclavian approach to TAVI

    Sheathless transradial intervention highly successful in treating complex lesions

    FDA approves study with Impella 2.5 to reduce heart muscle damage following PCI in STEMI patients

    Tryton announces investigational device exemption conditional approval from FDA to conduct US pivotal study of side branch stent

    European Commission approves ticagrelor tablets

    Eplerenone reduces risk of mortality in chronic heart failure patients with mild symptoms

    NICE guidance supports coronary drug-eluting balloon for in-stent restenosis

    TAVI should be new standard of care for “inoperable” patients

    Boston Scientific to acquire Sadra Medical

    Medtronic announces global launch of new heart valve repair ring

    Blue Medical receives CE mark approval for drug-eluting balloon and stent on drug eluting-balloon combination device

    Carmat announces agreement with Edwards Lifesciences to use the Carpentier-Edwards Biological Heart Valves in Artificial Heart

    Better preventative care could reduce coronary deaths in Europe

    Bioresorbable stent continues to show promising data

    Medtronic receives FDA approval for the Integrity coronary stent

    Combination of paclitaxel-coated balloon and EPC stent shows significantly lower late loss

    Studies presented at TCT favour everolimus-eluting stents

    All-cause mortality lower in patients treated with TAVI at one year

    PROMUS element stent approved for use in diabetic and heart attack patients in CE mark countries

    Edwards lifesciences launches Magna Mitral Ease Valve

    Medtronic gains CE mark for enhanced CoreValve delivery catheter system with AccuTrak stability layer

    Phase II study showed switching ACS-PCI patients to Effient from Plavix regimen reduced maximum platelet aggregation after one week

    Transfemoral or transapical aortic valve implantation?

    Long-term data further supports the benefit of Cypher compared to the Endeavor in high-risk subgroups

    InfraReDx receives FDA clearance for LipiScan IVUS coronary imaging system

    Cortisol levels in hair linked to heart attack risk

    HeartWare receives second patient allotment under continued access protocol for pivotal US bridge-to-transplant clinical trial

    Highlight from ESC 2010: A SHIFT in heart failure treatment

    Medtronic launches the Resolute Integrity Stent System

    CORDIS announces results of ten-year CYPHER sirolimus-eluting coronary stent follow-up

    New NICE guidance published to improve diagnosis and treatment of chronic heart failure

    Health care system delay may increase risk of death for heart patients receiving reperfusion therapy

    Mount Sinai researchers pioneer new method for detecting high-risk cardiovascular disease

    All Comers trial shows Resolute as good as Xience V at one year

    First ever patient given Biotronik DREAMS in Biosolve I Clinical Study

    FDA Advisory Committee recommends US approval of brilinta (ticagrelor) for ACS patients

    Boston Scientific begins clinical trial enrolment for new coronary stent with bioabsorbable polymer and everolimus drug coating

    Bayer’s Rivaroxaban meets primary endpoint in long-term Phase III Einstein-DVT study

    13-strong surgical team in training to implant new total artificial heart

    No firm conclusions about HDL cholesterol can be drawn from JUPITER sub-analysis

    MAQUET Cardiovascular launches advanced VASOVIEW technology for Endoscopic Vessel Harvesting procedures in cardiac surgery

    “Encouraging” TAVI results in high-risk patients

    Caduet reduces 10-year calculated risk of coronary heart disease, fatal cardiovascular disease

    Genfit announces its development plan for GFT505

    For heart failure patients, risk of in-hospital death has decreased; readmission rate has increased

    Rosiglitazone associated with increased cardiovascular risks and death

    Platinum Chromium Taxus Element stent system is launched in Europe

    Diabetic patients benefit from the Genous Bio-engineered R stent

    Bioresorbable stent one step closer to becoming a reality

    New expert guidelines allow more patients with pre-existing heart conditions to travel by air

    Rcadia COR Analyser System demonstrates potential for CAD triage in low risk patients

    REDUCE Clinical Study on target to impress, claims Gore

    St Jude Medical completes acquisition of LightLab Imaging

    World’s First Prohealing Stent Featured in Live Case Demo at AICT

    St Jude Medical announces initiation of a study to evaluate the economic impact of FFR in Europe and Canada

    Data presented at EuroPCR demonstrate effectiveness of the Genous Bio-engineered R stent in diabetic patients

    Edwards Sapien Transcatheter Heart Valve shows positive one-year outcomes in post-market study

    Medtronic CoreValve System shows long-term efficacy and durability in pivotal trial

    New data on Abbott’s Bioresorbable Vascular Scaffold reinforces its potential to be the next revolution in interventional cardiology

    Medtronic’s Resolute drug-eluting stent matches market-leading rival in large head-to-head study

    Tryton announces positive data from side branch system at EuroPCR

    Boston Scientific begins PLATINUM PLUS Trial for Promus Element Stent System

    Nevo sirolimus-eluting coronary stent continues to demonstrate excellent safety and efficacy outcomes in new 12-month data

    Boston Scientific announces CE mark and FDA approval of NC Quantum Apex Balloon Catheter

    Pantera Lux Paclitaxel Releasing Balloon is launched during the EuroPCR meeting

    MitraClip demonstrates strong safety results and improved clinical outcomes for common causes of leaky heart valves

    New data reinforces safety profile of Xience V

    Tryton side-branch stent launched in Europe

    Physio-Control launches new version of Lifenet

    No ACCORDance on role of fibrates

    Percutaneous device climbs to new heights in valvular therapy

    Cypher vs. Endeavor trial results cause a stir

    Data at JIM show bio-engineered stent may be good choice for patients not suitable for antiplatelet therapy

    FDA approves HeartMate II for destination therapy

    Resolute maintains sustained efficacy and safety in long-term follow-up

    Transcatheter heart valve replacement: A European perspective

    Abbott’s Xience V approved in Japan

    Controversy surrounds long-term lipid lowering therapy

    NICE recommends prasugrel plus aspirin for acute coronary syndromes

    Latest techniques showcased in Leipzig

    First patient enrolled in REMEDEE Combo Stent trial

    First transcatheter valve cases in Japan performed with Edwards Sapien valve

    Xience Prime and Xience V receive CE mark for treatment of diabetic patients

    Edwards Lifesciences’ newest aortic valve demonstrates no patient-prosthesis mismatch

    Two-year HORIZONS-AMI data continue to show superior efficacy for Taxus Express and bivalirudin in heart attack patients

    Trials show positive results for Xience V

    Intravascular ultrasound can predict events, PROSPECT shows

    MitraClip EVEREST registry results positive at TCT

    LEADERS two-year data: Biodegradable polymer technology is safe and effective

    LEADERS two-year data: Biodegradable polymer technology is safe and effective

    Symplicity Catheter System demonstrates durable blood pressure reduction in hypertension patients

    US surgeon performs first beating heart fully endoscopic bypass surgery using miniaturised Maquet’s cardiopulmonary bypass system

    Combo Stent may offer advantages to current drug-eluting stent technologies

    FAME demonstrates continued reduction in risk of death or heart attack with fractional flow reserve technology at two years

    Maquet receives FDA clearance for Mega, the world’s first 8F 50cc intra-aortic balloon catheter

    MitraClip shows sustained results in studies presented at TCT

    Taxus Liberte demonstrates improvements over Taxus Express in small vessels and long lesions

    Endeavor reduced risk of heart attack and cardiac death by 48% at three years compared to Taxus

    Blood flow blockages in the heart can be measured using wireless fractional flow reserve technology

    Resolute maintains sustained efficacy and safety in long-term follow-up

    Guided Delivery Systems successfully treats first patient with mitral regurgitation

    Novartis receives FDA approval for Valturna to treat high blood pressure

    Boston Scientific completes enrolment in pivotal trial for the Promus Element stent

    Boston Scientific announces release of next-generation iLab system software

    Genous Bio-engineered R stent is feasible

    Abbott announces Xience V approval in China

    KYOTO HEART shows benefits of valsartan

    Abbott to acquire Evalve, a leader in mitral valve repair technology

    First human cases performed with Edwards Lifesciences’ new transapical heart valve system

    CID announces CE mark of its new Avantgarde cobalt chrome Carbostent

    New drugs steal the spotlight at the ESC Congress 2009

    Women slightly more likely to die in the 30 days following a heart attack

    Drug-eluting stents are warranted for infarction

    Death rate decreases following hospitalisation for heart attack

    Genetic variation associated with outcomes with use of clopidogrel

    Health Canada approves Abbott’s Xience V

    Heart disease risk may come from little known type of cholesterol

    Syntax Score website: A tool for the best strategy

    Nevo yields superior results to Taxus in pivotal clinical trial

    FDA approves Boston Scientific’s Taxus Liberte Long Stent

    ASH: Darusentan helpful in resistant hypertension

    Effient is approved by the FDA

    Long-term recovery for DES is confirmed

    Tryton announces first patient enrolment in E-Tryton 150 Registry

    FDA approves dronedarone for patients with atrial fibrillation or atrial flutter

    Six month clinical outcomes of supralimus-sirolimus-eluting stent presented at EuroPCR

    New communication technologies help cardiac patients improve their prognosis

    Replagal shows significant benefits in women with Fabry disease

    Abbott enrolls first patient into SPIRIT PRIME trial in the US

    Pitavastatin demonstrates promise for low incidence of drug-drug interaction

    Combination therapy helped more patients reach combined targets for key lipid targets

    BARI 2D trial presented at the American Diabetes Association annual meeting

    Promising safety and efficacy results for Relaxin

    FDA approves next-generation Taxus Liberte Atom Stent System

    SCAAR registry provides reassurance on drug-eluting stent safety

    BI-204 shows positive results for prevention of events associated with atherosclerosis

    What is the future of cardiovascular surgery?

    New analysis evaluated impact of genetic variation on response to prasugrel

    One in 1,000 risk of death from catheter ablation for atrial fibrillation

    Ethnicity affects timing and access to cardiac care

    Chemical found in medical devices impairs heart function

    CID announces successful defence of European patent against an opposition filed by Conor Medsystem

    New enhancements to the Philips HeartStart MRx support fast triage of STEMI patients

    Statin therapy “highly effective and safe” in cardiac and noncardiac patients

    Better outcomes with bypass surgery for multivessel disease

    New target for maintaining healthy blood pressure discovered

    Novel system for diagnosis of stenosis allows prioritisation of critical cases

    Genous demonstrates “impressive” results in high-risk patients

    Fatty fish and marine omega-3 may reduce risk of heart failure

    St Jude Medical’s implantable cardioverter defibrillators receive CE mark

    ACC: Statins take centre stage again

    Five-in-one polypill may halve risk of cardiovascular disease

    BIBA Research’s fourth quarter 2008 report confirms recovery of drug-eluting stent use

    New tool calculates risk of bleeding in heart attack patients

    Study suggests black tea may help maintain cardiovascular function

    Maquet Cardiohelp wins design awards

    Screening diabetics for coronary disease does not reduce risk of cardiac events

    UK has its first percutaneous mitral valve repair patients

    Exercise may provide benefit for heart failure patients

    Two nondrug treatments appear to reduce depression after heart surgery

    Tips & tricks on PCI for chronic total occlusions

    New tests provide insight into why patients are in heart failure

    Medtronic announces international market release of Driver Sprint RX

    SYNTAX analysis favours PCI in many patients

    Lower risk of death and heart attack with drug-eluting stents

    More from JUPITER: Reduced risk of thromboembolism in healthy patients

    Surgery to reshape ventricle offers no added benefit over bypass graft

    Exenatide clinical data analysis shows no increased risk of cardiovascular events

    Salt consumption should be reduced to 1,500mg a day

    Boston Scientific’s rating outlook is raised

    Study shows finger device may help predict heart events

    Recently identified genetic heart disorder often deadly for young patients

    Siemens highlights C-reactive protein test at ACC09

    AstraZeneca calls on Americans to join US AGAINST ATHERO

    Infinitt North America to show new cardiology PACS solutions at ACC09

    Fully bioabsorbable drug-eluting stent next phase trial

    Mini-crush vs. T-provisional techniques in bifurcation lesions

    “Stent 4 Life” is launched to increase the use of primary PCI

    Taxus and Cypher safe for unprotected left main coronary artery disease

    Taxus reduces restenosis in saphenous vein graft lesions

    ATLANTA trial results are published

    Neurostimulation system for chronic angina receives CE mark

    Randomised trial will compare Nevo to Xience

    Two-year results of fully bioabsorbable drug-eluting stent published

    EUROASPIRE III: Treatment fails to meet standards of international guidelines

    GE’s first portable electrocardiogram cleared in the USA

    Heart attack: Why hospitalisation remains the same

    First patient is treated with CrossBoss and Stingray devices in the USA

    Abbott launches Voyager NC coronary balloon catheter

    PROTECT I assesses Impella’s safety

    Certain combined drugs following heart attack may increase risk of death

    Abnormal heart function associated with reduced capacity for exercise

    Guidelines for cardiovascular disease often based on weaker evidence

    Simple blood test may predict risk of heart attack

    Trials examine ACS strategies

    Beta-blocker linked to risks of death and MI after non-cardiac surgery

    Emerging therapies for antiplatelet inhibition

    CardioWest artificial heart approved for reimbursement in the US

    AneuGraft pericardium covered stent receives CE mark for tortuous vessels

    PressureWire Certus receives approval for physiological parameter measurements inside the heart

    Integuseal wins medical design award

    System for preparation of autologous fibrin sealant/PRF promoted at ESC

    JUPITER: reduced events in patients with low LDL, raised CRP

    FFR-guided stenting improves outcomes with fewer devices

    Why high pressure postdilatation with non-compliant balloons is required to optimise long-term DES outcomes

    Most read

    Features

    Profiles

    Bernardo Cortese

    Roxana Mehran

    Patrick Myers

    Cardiovascular News

    Write to us
    Editorial: Will Date will@bibamedical.com
    Advertising: Hannah Shiels hannah@bibamedical.com


    BIBA Medical, Europe
    526 Fulham Road, Fulham, London, SW6 5NR
    TEL: +44 (0)20 7736 8788
    Email: info@bibamedical.com

    Terms and Conditions | Privacy Policy
    Facebook Linkedin Mail X Youtube